PHASE III RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED, MULTICENTER, PARALLEL GROUP STUDY TO ASSESS THE EFFICACY AND SAFETY OF ADD-ON FIXED-DOSE ANTI-MYCOBACTERIAL THERAPY (RHB-104) IN MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE (MAP US)

David Y. Graham  1     Robert Hardi  2     Thomas Welton  3     Richard Krause  4     Scott Levenson  5     Harry Sarles  6     Aasim Sheikh     Michael S Epstein     George Duvall     Curtis Freedland     Zbigniew Hebzda     Tomasz Arlukowicz     Adam Kopon     Grzyna Rydzewska     Natasa Zdravkovic     Peter Svorcan     Eran Zittan     Predrag Dugalic     Eran Israeli     Patricia Anderson         
1 Baylor College of Medicine,Houston,United States
2 Chevy Chase Clinical Research,Rockville,United States
3 Cotton-O'Neil Clinical Research Center,Topeka,United States
4 ClinSearch,Chatanooga,United States
5 Digestive Care Associates, Inc.,San Carlos,United States
6 DHAT Research Institute / Digestive Health Associates of Texas,Richardson,U

Conference
UEG Week 2018

Citation
United European Gastroenterology Journal 2018; 6 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing